Adaptin Bio APTN
Adaptin Bio: annual report (amended)
- Form
- 10-K/A
- Filed
- Importance
- Routine
- Accession
- 0001213900-26-068261
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Artelo Biosciences ARTL public float $9M, Jun 30, 2025
- Bioxytran BIXT public float $9M, Jun 30, 2025
- Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025
- Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
- TherapeuticsMD TXMD public float $9M, Jun 30, 2025